Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.